AORT ARTIVION, INC.
NYSE · SEC CIK 784199 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $20.73M 46 sales by 8 insiders
- Filings on record
- 315 since 2021-08-24, latest 2026-09-11 17:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mackin James P | Pres, CEO | — | $9.72M |
| Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| Holloway Jean F | SVP, GC | — | $2.54M |
| Davis John E | Chief Commercial Off | — | $1.75M |
| GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| Horton Amy | VP, CAO | — | $870.1K |
| Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| Hoff Elizabeth A | Dir | — | $189.4K |
| SEMEDO ANTHONY B. | Dir | — | — |
| Borgstrom Marna P | Dir | — | — |
Transactions 430
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 | 2024-03-05 | AORT | GREEN ANDREW M | VP Regulatory | S - Sale | $18.72 | -1,160 | 46.5K | -2% | -$21.7K | |
| 2024-03-07 | 2024-03-01 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +3,578 | 47.7K | +8% | $0 | |
| 2024-03-07 | 2024-03-01 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +3,578 | 49.7K | +8% | $0 | |
| 2024-03-07 | 2024-03-05 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $18.72 | -1,157 | 48.5K | -2% | -$21.7K | |
| 2024-03-07 | 2024-03-01 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +3,578 | 141.1K | +3% | $0 | |
| 2024-03-07 | 2024-03-05 | AORT | Horton Amy | VP, CAO | S - Sale | $18.72 | -1,152 | 140.0K | -0.8% | -$21.6K | |
| 2024-03-07 | 2024-03-05 | AORT | Davis John E | Chief Commercial Off | S - Sale | $18.72 | -2,022 | 165.6K | -1% | -$37.9K | |
| 2024-03-07 | 2024-03-01 | AORT | Davis John E | Chief Commercial Off | A - Grant | $0.00 | +5,724 | 167.7K | +4% | $0 | |
| 2024-03-07 | 2024-03-05 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85.4K | -2% | -$28.2K | |
| 2024-03-07 | 2024-03-01 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +5,724 | 86.9K | +7% | $0 | |
| 2024-03-07 | 2024-03-01 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +28.6K | 719.6K | +4% | $0 | |
| 2024-03-07 | 2024-03-05 | AORT | Mackin James P | Pres, CEO | S - Sale | $18.72 | -14.0K | 705.6K | -2% | -$262.0K | |
| 2024-03-07 | 2024-03-05 | AORT | Holloway Jean F | SVP, GC | S - Sale | $18.72 | -2,380 | 169.7K | -1% | -$44.6K | |
| 2024-03-07 | 2024-03-01 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +5,724 | 172.0K | +3% | $0 | |
| 2024-03-07 | 2024-03-01 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +3,578 | 47.7K | +8% | $0 | |
| 2024-03-07 | 2024-03-05 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $18.72 | -1,157 | 46.5K | -2% | -$21.7K | |
| 2024-02-29 | 2024-02-27 | AORT | Holloway Jean F | SVP, GC | S - Sale | $19.83 | -485 | 166.3K | -0.3% | -$9,618 | |
| 2024-02-29 | 2024-02-27 | AORT | Mackin James P | Pres, CEO | S - Sale | $19.83 | -4,837 | 690.9K | -0.7% | -$95.9K | |
| 2024-02-29 | 2024-02-27 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $19.83 | -325 | 46.1K | -0.7% | -$6,445 | |
| 2024-02-29 | 2024-02-27 | AORT | Horton Amy | VP, CAO | S - Sale | $19.83 | -325 | 137.5K | -0.2% | -$6,445 | |
| 2024-02-29 | 2024-02-27 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $19.83 | -370 | 44.1K | -0.8% | -$7,337 | |
| 2024-02-29 | 2024-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81.2K | -0.6% | -$9,221 | |
| 2024-02-29 | 2024-02-27 | AORT | Tyrs Florian | VP, Gbl Ops | S - Sale | $19.83 | -339 | 21.6K | -2% | -$6,722 | |
| 2024-02-29 | 2024-02-27 | AORT | GREEN ANDREW M | VP Regulatory | S - Sale | $19.83 | -421 | 44.1K | -0.9% | -$8,348 | |
| 2024-02-29 | 2024-02-27 | AORT | Davis John E | Chief Commercial Off | S - Sale | $19.83 | -584 | 161.9K | -0.4% | -$11.6K | |
| M | 2024-02-28 | 2024-02-23 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +18.2K | 156.9K | +13% | $0 |
| M | 2024-02-28 | 2024-02-26 | AORT | Holloway Jean F | SVP, GC | S - Sale | $20.27 | -2,880 | 166.8K | -2% | -$58.4K |
| M | 2024-02-28 | 2024-02-26 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $20.27 | -2,313 | 40.1K | -5% | -$46.9K |
| M | 2024-02-28 | 2024-02-23 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +10.8K | 41.3K | +35% | $0 |
| M | 2024-02-28 | 2024-02-26 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,048 | 72.5K | -4% | -$61.8K |
| M | 2024-02-28 | 2024-02-23 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +16.0K | 74.1K | +28% | $0 |
| M | 2024-02-28 | 2024-02-23 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +99.1K | 668.4K | +17% | $0 |
| M | 2024-02-28 | 2024-02-26 | AORT | Mackin James P | Pres, CEO | S - Sale | $20.27 | -31.3K | 695.8K | -4% | -$634.7K |
| M | 2024-02-28 | 2024-02-23 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +10.3K | 40.0K | +35% | $0 |
| M | 2024-02-28 | 2024-02-26 | AORT | GREEN ANDREW M | VP Regulatory | S - Sale | $20.27 | -2,403 | 38.8K | -6% | -$48.7K |
| M | 2024-02-28 | 2024-02-23 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +9,784 | 45.6K | +27% | $0 |
| M | 2024-02-28 | 2024-02-26 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $20.27 | -2,315 | 44.5K | -5% | -$46.9K |
| M | 2024-02-28 | 2024-02-26 | AORT | Horton Amy | VP, CAO | S - Sale | $20.27 | -2,166 | 137.9K | -2% | -$43.9K |
| M | 2024-02-28 | 2024-02-23 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +9,784 | 133.6K | +8% | $0 |
| 2024-02-28 | 2024-02-26 | AORT | Tyrs Florian | VP, Gbl Ops | S - Sale | $20.27 | -893 | 21.9K | -4% | -$18.1K | |
| M | 2024-02-28 | 2024-02-26 | AORT | Davis John E | Chief Commercial Off | S - Sale | $20.27 | -3,514 | 151.7K | -2% | -$71.2K |
| M | 2024-02-28 | 2024-02-23 | AORT | Davis John E | Chief Commercial Off | A - Grant | $0.00 | +18.1K | 164.4K | +12% | $0 |
| 2024-02-26 | 2024-02-23 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +7,893 | 37.0K | +27% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +19.6K | 151.5K | +15% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +14.8K | 68.7K | +27% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Berry Lance A | CFO, Executive VP | A - Grant | $0.00 | +37.0K | 79.1K | +88% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Davis John E | Chief Commercial Off | A - Grant | $0.00 | +19.7K | 147.9K | +15% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Tyrs Florian | VP, Gbl Ops | A - Grant | $0.00 | +6,537 | 22.8K | +40% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +11.1K | 36.7K | +43% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +7,893 | 130.2K | +6% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +89.0K | 628.0K | +17% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | THOMSON ROBERT C | VP Research, Development | A - Grant | $0.00 | +8,165 | 13.3K | +159% | $0 | |
| 2024-02-26 | 2024-02-23 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +9,250 | 37.9K | +32% | $0 | |
| M | 2024-02-22 | 2024-02-20 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $18.87 | -1,695 | 29.1K | -6% | -$32.0K |
| DM | 2024-02-22 | 2024-02-20 | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $18.85 | -72.1K | 541.8K | -12% | -$1.36M |
| D | 2024-02-22 | 2024-02-20 | AORT | Mackin James P | Pres, CEO | M - OptEx | $16.30 | +59.2K | 611.1K | +11% | +$965.4K |
| M | 2024-02-22 | 2024-02-20 | AORT | Davis John E | Chief Commercial Off | S - Sale | $18.87 | -2,556 | 128.2K | -2% | -$48.2K |
| 2024-02-22 | 2024-02-20 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $18.87 | -407 | 29.1K | -1% | -$7,680 | |
| M | 2024-02-22 | 2024-02-20 | AORT | Holloway Jean F | SVP, GC | S - Sale | $18.87 | -3,527 | 133.5K | -3% | -$66.6K |
| 2024-02-22 | 2024-02-20 | AORT | Tyrs Florian | VP, Gbl Ops | S - Sale | $18.87 | -249 | 16.3K | -2% | -$4,699 | |
| M | 2024-02-22 | 2024-02-20 | AORT | Horton Amy | VP, CAO | S - Sale | $18.87 | -1,695 | 122.7K | -1% | -$32.0K |
| D | 2024-01-04 | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | M - OptEx | $16.30 | +21.2K | 154.7K | +16% | +$346.0K |
| D | 2024-01-04 | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | S - Sale+OE | $18.00 | -21.2K | 133.5K | -14% | -$382.1K |
| D | 2024-01-04 | 2024-01-02 | AORT | Davis John E | Senior VP, Gbl Sales | M - OptEx | $16.30 | +13.6K | 142.3K | +11% | +$221.1K |
| D | 2024-01-04 | 2024-01-02 | AORT | Davis John E | Senior VP, Gbl Sales | S - Sale+OE | $18.00 | -13.6K | 128.7K | -10% | -$244.1K |
| D | 2023-12-19 | 2023-12-15 | AORT | Horton Amy | VP, CAO | S - Sale+OE | $19.00 | -14.4K | 124.0K | -10% | -$273.5K |
| D | 2023-12-19 | 2023-12-15 | AORT | Horton Amy | VP, CAO | M - OptEx | $16.30 | +14.4K | 138.4K | +12% | +$234.7K |
| 2023-12-08 | 2023-12-06 | AORT | Horton Amy | VP, CAO | A - Grant | $17.83 | +20.2K | 124.0K | +19% | +$360.0K | |
| D | 2023-12-08 | 2023-12-06 | AORT | Berry Lance A | CFO, Executive VP | A - Grant | $17.83 | +42.1K | 42.1K | New | +$750.0K |
| 2023-11-29 | 2023-11-27 | AORT | Horton Amy | VP, CAO | G - Gift | $17.51 | -1,750 | 103.8K | -2% | -$30.6K | |
| 2023-11-29 | 2023-11-27 | AORT | Horton Amy | VP, CAO | S - Sale | $17.34 | -2,101 | 105.6K | -2% | -$36.4K | |
| D | 2023-08-10 | 2023-08-08 | AORT | Tyrs Florian | VP, Gbl Ops | A - Grant | $16.79 | +2,107 | 16.5K | +15% | +$35.4K |
| D | 2023-06-12 | 2023-06-09 | AORT | THOMSON ROBERT C | VP Research, Development | A - Grant | $15.49 | +5,126 | 5,126 | New | +$79.4K |
| 2023-06-08 | 2023-06-06 | AORT | ACKERMAN THOMAS F | Dir | A - Grant | $0.00 | +9,709 | 137.3K | +8% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | Salveson Jon W | Dir | A - Grant | $0.00 | +9,709 | 117.2K | +9% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | SEMEDO ANTHONY B. | Dir | A - Grant | $0.00 | +9,709 | 37.6K | +35% | $0 | |
| 2023-06-08 | 2023-06-07 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $15.88 | -6,329 | 30.4K | -17% | -$100.5K | |
| 2023-06-08 | 2023-06-06 | AORT | Hoff Elizabeth A | Dir | A - Grant | $0.00 | +9,709 | 18.8K | +107% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | Borgstrom Marna P | Dir | A - Grant | $0.00 | +9,709 | 36.5K | +36% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | Bullock James | Dir | A - Grant | $0.00 | +9,709 | 56.0K | +21% | $0 | |
| M | 2023-06-08 | 2023-06-06 | AORT | Maier Dennis B | SVP, Ops | S - Sale | $15.27 | -16.3K | 35.1K | -32% | -$248.2K |
| 2023-06-08 | 2023-06-06 | AORT | Burbank Jeffrey H | Dir | A - Grant | $0.00 | +9,709 | 41.2K | +31% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | BEVEVINO DANIEL J | Dir | A - Grant | $0.00 | +9,709 | 137.4K | +8% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Davis John E | Senior VP, Gbl Sales | S - Sale | $13.41 | -1,121 | 128.7K | -0.9% | -$15.0K | |
| 2023-03-03 | 2023-03-01 | AORT | Davis John E | Senior VP, Gbl Sales | A - Grant | $0.00 | +3,663 | 129.9K | +3% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | S - Sale | $13.41 | -1,401 | 347.2K | -0.4% | -$18.8K | |
| 2023-03-03 | 2023-03-01 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | A - Grant | $0.00 | +4,579 | 348.6K | +1% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Horton Amy | VP, CAO | S - Sale | $13.41 | -702 | 107.7K | -0.6% | -$9,414 | |
| 2023-03-03 | 2023-03-01 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +2,290 | 108.4K | +2% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Maier Dennis B | SVP, Ops | S - Sale | $13.41 | -1,121 | 51.0K | -2% | -$15.0K | |
| 2023-03-03 | 2023-03-01 | AORT | Maier Dennis B | SVP, Ops | A - Grant | $0.00 | +3,663 | 52.1K | +8% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $13.41 | -907 | 52.1K | -2% | -$12.2K | |
| 2023-03-03 | 2023-03-01 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +3,663 | 53.0K | +7% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $13.41 | -702 | 36.7K | -2% | -$9,414 | |
| 2023-03-03 | 2023-03-01 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +2,290 | 37.4K | +7% | $0 | |
| 2023-03-03 | 2023-03-01 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +21.8K | 561.9K | +4% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Mackin James P | Pres, CEO | S - Sale | $13.41 | -9,990 | 551.9K | -2% | -$134.0K | |
| 2023-03-03 | 2023-03-02 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $13.41 | -821 | 29.5K | -3% | -$11.0K | |
| 2023-03-03 | 2023-03-01 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +2,290 | 30.4K | +8% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | Holloway Jean F | SVP, GC | S - Sale | $13.41 | -907 | 133.5K | -0.7% | -$12.2K |
Purchase Sale Sale after option exercise All abbreviations